(redirected from Chronic Non-Cancer Pain)
CNCPChina National Petroleum Corporation
CNCPCommission Nationale de la Certification Professionnelle (French: National Commission for Vocational Certification)
CNCPChronic Non-Cancer Pain
CNCPCarbon Neutral Capital Program (Canada)
CNCPCaisse Nationale de Crédit Professionnel (French: National Professional Credit Fund; Belgium; est. 1946)
CNCPClub Nautique de Châtelaillon-Plage (French yacht club)
CNCPCanadian Nursery Certification Program
CNCPCanadian National/Canadian Pacific (telecommunications company)
CNCPCanada Prenatal Nutrition Program
CNCPCommonwealth National Competition Policy (Australia)
CNCPCertified Nanotechnology and Clean Technology Professional (California Institute of Nanotechnology; San Jose, CA)
CNCPCritical Need Certification Program (South Carolina teaching certificate)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
In patients receiving opioid therapy for chronic non-cancer pain, the prevalence of OIC ranges from approximately 40-60%.
Overdose and prescribed opioids: Associations among chronic non-cancer pain patients.
Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Recognizing inadequacies in the management of chronic non-cancer pain, several pain societies and others advocated a more liberal use of opioids for non-cancer pain.
A comparison of long- and short-acting opioids for the treatment of chronic non-cancer pain: Tailoring therapy to meet patient needs.
As part of the Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS), that started in 2004, the researchers followed 215 adult patients, with chronic non-cancer pain, who used medical cannabis, and compared them to a control group of 216 chronic pain sufferers who were not cannabis users.
Repeated careful review of patients on long term opiate therapy for chronic non-cancer pain must be emphasised however, with up to 19% of chronic pain patients found to have some form of addictive disorder in a 2001 paper on the subject (14) courtesy of the BJA.
(4) Like the Chicago FAC, the Petition directly challenged the use of opioids for "chronic non-cancer pain." PROP contended that the "long-term safety and effectiveness of managing [chronic non-cancer pain] with opioids has not been established," and requested that the FDA, inter alia, impose a "maximum duration of 90-days for continuous (daily) use for non-cancer pain." The FDA "carefully reviewed" the Petition and "more than 1900 [related] comments." The agency assessed the "relevant literature." It held a two-day public hearing at which it received "over 600 comments" and dozens of experts and concerned citizens testified.
Opioids for chronic non-cancer pain. British Medical Journal, 346(2931), 38-41.
Hamburg's support for using opioids to treat chronic non-cancer pain is squarely at odds with efforts by the CDC to discourage this widespread practice,'' states the letter, which is signed by the National Coalition Against Prescription Drug Abuse and 15 other groups.
McQuay, "Opioids in chronic non-cancer pain: systematic review of efficacy and safety," Pain, vol.
The South African guideline for the use of chronic opioid therapy for chronic non-cancer pain (CNCP) [6] developed by a multi-disciplinary panel provides recommendations for patient selection and the use of opioids for CNCP.
Full browser ?